1. Roles of Androgen Receptor Signaling in Urothelial Carcinoma
   Debasish Sundi et al, 2024, Cancers CrossRef
2. Mechanisms of Sex Disparities in Cardiovascular Function and Remodeling
   Sarika Chaudhari et al, 2018, Comprehensive Physiology CrossRef
3. EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation
   Hubin Yin et al, 2022, Cell Death & Disease CrossRef
4. The emerging role of the androgen receptor in bladder cancer
   Alan P Lombard et al, 2015, Endocrine-Related Cancer CrossRef
5. Understanding the biology of urothelial cancer metastasis
   Takashi Kobayashi, 2016, Asian Journal of Urology CrossRef
6. Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation
   Zhao Yang et al, 2020, Cancer Letters CrossRef
7. Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals
   Gang Deng et al, 2021, Cell Death & Differentiation CrossRef
8. Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study
   Edwin E. Morales et al, 2016, European Urology CrossRef
9. Potential therapeutic effects of N-butylidenephthalide from Radix Angelica Sinensis (Danggui) in human bladder cancer cells
   Sheng-Chun Chiu et al, 2017, BMC Complementary and Alternative Medicine CrossRef
10. Endocrine-disrupting effects of bisphenols on urological cancers
    Eve Pellerin et al, 2021, Environmental Research CrossRef
11. Androgen receptor activation: a prospective therapeutic target for bladder cancer?
    Taichi Mizushima et al, 2017, Expert Opinion on Therapeutic Targets CrossRef
12. Role of the androgen receptor in urothelial cancer
    Satoshi Inoue et al, 2018, Molecular and Cellular Endocrinology CrossRef
13. The route to personalized medicine in bladder cancer: where do we stand?
    Francesco Massari et al, 2015, Targeted Oncology CrossRef
14. Emerging concepts on drug resistance in bladder cancer: Implications for future strategies
    Francesco Massari et al, 2015, Critical Reviews in Oncology/Hematology CrossRef
15. Cancer Genetics at a Glance: The Comprehensive Insights
    Asaad Azarnezhad et al, 2017, Cancer Genetics and Psychotherapy CrossRef
16. Auranofin lethality to prostate cancer includes inhibition of proteasomal deubiquitinases and disrupted androgen receptor signaling
    Ningning Liu et al, 2019, European Journal of Pharmacology CrossRef
17. Targeted therapies in bladder cancer: an overview of in vivo research
    Kim E. M. van Kessel et al, 2015, Nature Reviews Urology CrossRef
18. Androgen Receptor Signaling in Bladder Cancer
    Peng Li et al, 2017, Cancers CrossRef
19. The androgen receptor in bladder cancer
    Jinbo Chen et al, 2023, Nature Reviews Urology CrossRef
20. Enzalutamide inhibits androgen receptor–positive bladder cancer cell growth
    Takashi Kawahara et al, 2016, Urologic Oncology: Seminars and Original Investigations CrossRef
21. Impact of Finasteride on Survival in Bladder Cancer: A Retrospective Multi-institutional Database Analysis
    Harshit Garg et al, 2023, Clinical Genitourinary Cancer CrossRef
22. Androgen deprivation therapy prevents bladder cancer recurrence
    Koji Izumi et al, 2014, Oncotarget CrossRef